Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
Alzheimer's disease (AD) is one of the most prevalent neurodegenerative disorders worldwide, requiring early identification for timely intervention and to slow disease progression. However, existing diagnostic approaches, while effective at later stages, remain limited in detecting early-stage AD. Handwriting analysis has recently emerged as a non-invasive, cost-effective, and ecologically valid d...
Label-free surface-enhanced Raman spectroscopy (SERS) offers a promising avenue for rapid metabolic phenotyping in complex biofluids, yet its translational potential is hindered by the challenge of deconvoluting overlapping spectral contributions and identifying specific metabolite signatures. Herein, we report a liquid chromatography-mass spectrometry (LC-MS)-guided AI enabled serum molecule-inte...
Progesterone (PG) is used to slow the progression of neurodegenerative diseases, particularly Alzheimer's disease (AD) in postmenopausal women. Howeve...
BACKGROUND: Digital health tools, particularly patient portals, can support caregiving, but there is limited understanding of how sociodemographic and...
INTRODUCTION: Idiopathic normal pressure hydrocephalus (iNPH) is frequently underdiagnosed due to non-specific symptoms and the risks of invasive test...
BACKGROUND: Less women participate in Alzheimer Disease (AD) trials compared to their estimated representation in the global dementia population. OBJE...
While children with suicidal ideation or non-suicidal self-injury (NSSI) are at high risk of suicide, most do not attempt suicide. This study aims to ...
INTRODUCTION: Increased global lifespan is paralleled by a rise in non-communicable diseases with osteoarthritis and dementia, including Alzheimer's d...
BACKGROUND: Over the past decade, neuropsychopharmacology has shifted from stagnation to momentum, with first-in-class mechanisms and biomarker-enable...
BACKGROUND: Glymphatic system (GS) function and hippocampal microstructural changes are promising imaging markers of Alzheimer's disease (AD). This st...
BACKGROUND: Late-life depression (LLD) often co-occurs with mild cognitive impairment (MCI), and patients with LLD and MCI (LLD-MCI) have an increased...
OBJECTIVE: Mild cognitive impairment (MCI) is an intermediary stage between typical cognitive aging and dementia. Identifying reliable biomarkers for ...
INTRODUCTION: Thematic coding helps researchers characterize intervention implementation in embedded pragmatic clinical trials (ePCTs), particularly i...
AimTo evaluate and compare the performance of five artificial intelligence (AI) chatbots-ChatGPT (OpenAI 4), Google Gemini, Grok (xAI), DeepSeek, and ...
BACKGROUND AND OBJECTIVES: Respite care provides temporary relief to family caregivers yet remains underused, and the factors shaping its utilization ...
BackgroundPeople living with dementia (PLWD) with advanced illness are prone to respiratory distress yet often cannot self-report dyspnea, delaying re...
Accurate disease prognosis is essential for patient care but is often hindered by the scarcity of longitudinal data. This study explores deep learning...
People with semantic dementia (SD) or semantic variant primary progressive aphasia typically present with marked atrophy of the anterior temporal lobe...
Protein phosphorylation is one of the most prevalent post-translational modifications regulating biological functions, and its dysregulation is closel...
BackgroundLucid episodes (LEs) in advanced dementia are significant clinical events yet are challenging to investigate as they are characterized by a ...